Although CCL20 is known to induce ERK1/2 signaling in lung cancer cells 43, we did not observed the attenuation of ERK1/2 signaling following knockdown of CCL20 in PC cell lines, suggesting that CCL20 signaling might activate differential downstream signaling dependent in specific cancer types. The gene discussed is MAPK3; the disease is pachyonychia congenita.